Trans-rectal Versus Trans-Perineal Saturation Rebiopsy of the Prostate: Is There a Difference in Cancer Detection Rate?

Abdollah, Firas; Novara, Giacomo; Briganti, Alberto; Scattoni, Vincenzo; Raber, Marco; Roscigno, Marco; Suardi, Nazareno; Gallina, Andrea; Artibani, Walter; Ficarra, Vincenzo; Cestari, Andrea; Guazzoni, G.; Rigatti, Patrìzio; Montorsi, Francesco

doi:10.1016/j.urology.2010.08.048

Cited by 92 publications

(71 citation statements)

References 20 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Consistent with previous reports (9,11,22,26,28,30), the current study demonstrated that a higher PSA level at repeat biopsy, lower prostate volume and elevated PSAD, were associated with a higher rate of PCa detection. In the context of repeat biopsy, intensive saturation biopsies should be recommended in patients with a smaller prostate volume or increased PSAD.…”

Section: Discussionsupporting

confidence: 92%

“…Biopsy cores were taken from 24 biopsy locations based on a standardized biopsy scheme (Fig. 1) described by Abdollah et al (9), with some modification. Biopsy cores of odd numbers were taken from the apex, whereas cores of even numbers were taken from the base of the prostate.…”

Section: Trus-guided Systematic Biopsymentioning

confidence: 99%

“…PCa was confirmed histologically in 16 of the 78 patients (20.5%), and benign prostatic disease (BPD) was diagnosed in the remaining 62 patients (79.5%) based Figure 1. Biopsy cores were taken from 24 locations based on a standardized biopsy scheme (Abdollah et al) (9). The biopsy cores of odd numbers were taken from the apex, whereas cores of even numbers were taken from the base of the prostate.…”

Section: Patient Characteristicsmentioning

confidence: 99%

“…The benefits of increasing the number of biopsy cores and/or expanding the number of regions sampled have been demonstrated previously (5,6); however, it has also been suggested that a 10-to 12-core initial biopsy may miss PCa in almost a third of cases (7,8). Saturation prostate biopsy, which consists of ≥20 cores, has been developed to improve the detection rate of PCa in the context of repeat biopsies, radically altering the general concept of prostate biopsy (9)(10)(11)(12).…”

Section: Introductionmentioning

confidence: 99%

See 3 more Smart Citations

Analysis of repeated 24-core saturation prostate biopsy: Inverse association between asymptomatic histological inflammation and prostate cancer detection

et al. 2016

View full text Add to dashboard Cite

show abstract

Section: Discussionsupporting

confidence: 92%

Section: Trus-guided Systematic Biopsymentioning

confidence: 99%

Section: Patient Characteristicsmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Analysis of repeated 24-core saturation prostate biopsy: Inverse association between asymptomatic histological inflammation and prostate cancer detection

et al. 2016

View full text Add to dashboard Cite

show abstract

“…Supporters of transperineal approach suggest transperineally apical and anterior parts of the prostate may be better accessed compared to transrectal approach. For those reasons, studies were designed to compare yields of transrectal versus transperineal biopsy approach in primary 12-core and saturation 20-core schemes (Hara et al, 2008;Abdollah et al, 2011). Those studies uniformly showed no difference in cancer yields.…”

Section: Transrectal or Transperineal Approach?mentioning

confidence: 99%

Future of Prostate Biopsy: Who Will Get It and How?

Hajdinjak¹

2011

Prostate Cancer - Diagnostic and Therapeutic Advances

View full text Add to dashboard Cite

Evaluation of cell‐free DNA accuracy as diagnostic biomarker for prostate cancer: A systematic review and meta‐analysis

Chen

Sadeghi

2021

Biotech and App Biochem

View full text Add to dashboard Cite

This updated meta-analysis aimed to assess the diagnostic performance of circulating cell-free DNA (cf-DNA) for prostate cancer (PCa). Methods: A systematic search was conducted in PubMed, Scopus, Web of Science, and Embase databases to retrieve related studies. Several diagnostic estimates, including sensitivity (SE), specificity (SP), likelihood ratios (LRs), and diagnostic odds ratio (DOR) were also used to perform the meta-synthesis. Additionally, the area under hierarchical summary receiver operating characteristic curves (AU-HSROC) was used as a global measure of test accuracy. Results: Twenty-nine unique articles were enrolled in the meta-analysis. Pooled SE and SP for overall accuracy of cf-DNA in PCa were obtained as 0.54 (95% CI: 0.47-0.61) and 0.92 (95% CI: 0.88-0.95), respectively. Positive LR (PLR) was 6.8 (95% CI: 4.9-9.5, I 2 : 92.98%) and negative LR (NLR) was 0.5 (95% CI: 0.43-0.58).Pooled DOR was 13.56 (95% CI: 9.49-19.37) and the AU-HSROC was 0.83 (95% CI: 0.79-0.86). Conclusion:The present study suggested that cf-DNA assays have comparable SE as well as remarkably higher SP (qualitative assays) than common biomarkers in the detection of PCa like prostate-specific antigen (PSA). In addition, cf-DNA assays have better performance in PCa confirmation and almost similar performance to PSA in excluding PCa patients.

show abstract

Trans-rectal Versus Trans-Perineal Saturation Rebiopsy of the Prostate: Is There a Difference in Cancer Detection Rate?

Cited by 92 publications

References 20 publications

Analysis of repeated 24-core saturation prostate biopsy: Inverse association between asymptomatic histological inflammation and prostate cancer detection

Analysis of repeated 24-core saturation prostate biopsy: Inverse association between asymptomatic histological inflammation and prostate cancer detection

Future of Prostate Biopsy: Who Will Get It and How?

Evaluation of cell‐free DNA accuracy as diagnostic biomarker for prostate cancer: A systematic review and meta‐analysis

Contact Info

Product

Resources

About